
Sign up to save your podcasts
Or
In this Mission Matters episode, Adam Torres interviews Karen Ho, Founder and CEO of Lumina BioConsulting, about her mission to fast-track therapies for pediatric rare diseases. Drawing on personal experience and deep scientific expertise, Karen explains how cutting-edge biotech and regulatory flexibility are opening new doors for children previously left without options.
This interview is part of the Milken Global Conference coverage by Mission Matters. Big thanks to the Milken Institute for inviting us to cover the conference.
Apply to be a guest on our podcast:
https://missionmatters.lpages.co/podcastguest/
Visit our website:
https://missionmatters.com/More FREE content from Mission Matters here: https://linktr.ee/missionmattersmedia
Learn more about your ad choices. Visit podcastchoices.com/adchoices
3.7
33 ratings
In this Mission Matters episode, Adam Torres interviews Karen Ho, Founder and CEO of Lumina BioConsulting, about her mission to fast-track therapies for pediatric rare diseases. Drawing on personal experience and deep scientific expertise, Karen explains how cutting-edge biotech and regulatory flexibility are opening new doors for children previously left without options.
This interview is part of the Milken Global Conference coverage by Mission Matters. Big thanks to the Milken Institute for inviting us to cover the conference.
Apply to be a guest on our podcast:
https://missionmatters.lpages.co/podcastguest/
Visit our website:
https://missionmatters.com/More FREE content from Mission Matters here: https://linktr.ee/missionmattersmedia
Learn more about your ad choices. Visit podcastchoices.com/adchoices
7 Listeners
54 Listeners
2 Listeners
0 Listeners
7 Listeners
2 Listeners
1 Listeners
1 Listeners